Rankings Commodities & uranium Centrus Energy
Centrus Energy
43
15070100
A view of the same findings, not a new score. How it works
The model found several serious problems. That does not mean the stock will fall.
Biggest deductions
- Multiples vs own history and peers−30
- Margin−8
- Dilution−8
Strengths
- Order+3
- Net cash+2
- Long-term order book+1
How the score is built
From 100 to 43, step by step: points off for the business, the price and the cracks, back for documented strengths, then three data adjustments.
Start
Score
Hover or select a step to see what drove it. Steps with findings open them below.
Key numbers
As of 2 Nov 2026. Analyst targets tend to be optimistic; read upside as a hint, not a forecast.
- Price
- 94.90 USD
- Median analyst target
- 188.00 USD
- Upside to median
- +98.1%
- Analysts
- 20
- Target range
- 115.00 – 337.00 USD
- 52-week change
- −74%
- P/E (trailing)
- 43.7
- Forward P/E
- 34.9
- PEG
- n/a
Findings
Every deduction and every plus, with its source. Open a step to read them.
Business
Is the company getting stronger, not just bigger? · 4 findings−18 of −30
- −8MarginOperating margin 0.1% TTM vs 45.6% (2021), 22.7–23.6% (2022–23), 14.2% (2024) and 9.7% (2025). The gross margin has fallen from 38–40% to 23.7%, and SWU unit costs rose 13% in Q2.
- −4ROICROIC 0.4% and ROCE 0.0% TTM vs a WACC of 8.5%. Invested capital has grown sharply with convertible notes and share issues, while operating profit has fallen to $0.5m.
- −2Quality of earningsNet profit of $48.5m TTM comes almost entirely from interest income on the cash ($16.3m in Q2 alone), not from operations, which delivered operating profit of $0.5m.
- −4Quality of growthRevenue is expected to rise only 5% in 2026 and 0.3% in 2027 (guidance $450–500m). SWU volume fell 23% in Q2; growth came from low-margin uranium sales.
Price
Today's multiples against the company's own history and its peers. · 1 finding−30 of −35
- −30Multiples vs own history and peersForward P/E 57 vs its own forward history of 12.7–22.1 (2021–24) and 67 (2025); trailing P/E 65 vs 5–15 (2021–24); EV/EBITDA 216 vs 4.4–14.5 (2021–24); P/S 6.1 vs 1.6–2.7 (2021–24). The stock is −54% over 52 weeks but still priced at several times its own history with no earnings growth.
Cracks
Cash flow, customers, debt, insiders, guidance and what sits behind the headline numbers. · 5 findings−22 of −35
- −8DilutionThe share count has risen 31% in a year. On 9/9 $500m was raised at $199.64 per share with warrants for up to 6.99m more shares in four series (exercise prices $227–363). That is up to about +34% on top of the 20.5m shares. The price has since fallen to about $140.
- −5Cash flowFCF −$164m TTM (operating cash flow −$55m); capex is guided at $350–500m in 2026, and analysts expect FCF of −$296m.
- −5Russia (TENEX)Over half of the LEU deliveries planned through 2027 come from TENEX, and other sources cannot replace them. Russia requires a separate export licence for each shipment, and US waivers only cover deliveries through 2027.
- −2Government dependenceTechnical Solutions posted a gross loss of $1.7m in Q2, and the DOE's 2027 budget proposal contains no further funds for the HALEU operations contract.
- −2ExecutionAbout $3.0bn of the $3.7bn LEU backlog is contingent contracts that require the Piketon capacity to be built. The first new centrifuge in Oak Ridge is only expected to be finished by year-end.
Plus
Only documented strengths. · 3 findings+6 of +15
- +3OrderA $900m DOE contract for HALEU expansion in Piketon and the first large commercial HALEU supply agreement, possibly with prepayments.
- +2Net cashCash $1.87bn vs convertible notes of $1.18bn, i.e. net cash of $691m at 30/6 (before the $500m September share issue).
- +1Long-term order bookTotal backlog of $4.5bn stretching to 2040; about $1.5bn of it is unconditional.
Caveats
What the score does not capture, or where the data is weak.
No revenue growth and operating profit around zero; the profit is interest on cash. +31% more shares, and warrants from the September issue may add up to 7m more shares. Over half of LEU deliveries through 2027 come from Russia's TENEX. 26.5% of the shares are sold short. The market value at stockanalysis may not include all new shares from September.
Also in Commodities & uranium
The highest scores in the same industry.
